What are you looking for?

Flask in scientist hand with laboratory background

Web Seminar: Quality Control of Vaccines and Other Pharmaceutical Preparations by Total Nitrogen Determination November 3, 2022 - 10:00 am CEST & 3:00 pm CEST

Register here

Quality Control of Vaccines and Other Pharmaceutical Preparations

Speaker: 
Oliver Buettel, Director Product Management and Applications, Analytik Jena US LLC

Contents of the web seminar

Duration: ~60 min
Language: English

Base: featured study, the catalytic combustion method with chemiluminescence detection (CLD) utilize for total protein analysis according to USP <1057> Method 7 is considered and as described in the Pharm. Eur. Monograph 2.5.33, Method 7B. A simple, rapid and robust method was developed on the Analytik Jena multi N/C 2100S pharma — a Total Organic Carbon and Total Bound Nitrogen (TOC/TNb) analyzer specifically designed for pharmaceutical applications — to obtain total bound nitrogen. The TNb can be easily converted into total protein. Vaccine and allergen extracts were analyzed in this study. The allergen extracts usually contain high percent of glycerol which makes protein analysis challenging. The result demonstrated no analytical interference from the high glycerol content.
Here, the featured speaker will explore the quality control of vaccines and other pharmaceutical preparations.

Who Should Attend?
The following professionals in the pharmaceutical industry:

  • QC Managers and Technicians
  • Production Managers and Technicians
  • R&D Managers and Technicians
  • Lab Managers
  • Researchers

What You Will Learn
Attendees will gain insights into:

  • Comparison of combustion elemental analysis with traditional methods for total nitrogen determination
  • Principle of nitrogen determination by catalytic combustion
  • HData integrity and regulatory compliance

The newsletter of Analytik Jena frequently keeps you posted about:

  • News
  • Trends and developments
  • Events

Sign up here

This website uses cookies

To optimize our website and offer you relevant content and personalized advertising, we access information (e.g. device recognition, browser information) in your terminal device and store this information (such as cookies or other technologies) in your terminal device. In this way, we measure how and with what you use our offers. We also share the (personal) data collected in the process with third parties. By clicking “Accept all”, you agree (revocable at any time for the future) to the storage and data processing.

In the settings you can individually adjust your voluntary consent at any time or grant/withdraw consent for individual purposes. You can find more information in the privacy policy.

If you are under 16 and wish to give your consent to voluntary services, you must ask your legal guardian for permission.

Note on data transfer outside the EU: In some cases, data might be processed outside the European Union in the context of the use of third-party services. This only takes place if the special requirements of Art. 44 et seq. GDPR are fulfilled. Data is transmitted for the purpose of compiling statistics and implementing marketing measures. Further information can be found in our privacy policy.

Consent Management

We respect your right to privacy. You can decide for yourself which types of cookies you want to accept when visiting the website and which not.

Category Description Status
Necessary These cookies are responsible for the provision of the most important website functionalities, e.g. for saving data protection and content settings. They also enable us to measure and aggregate anonymous user behavior data to improve our website.
Statistics These cookies measure - anonymously and aggregated - the success of our advertising. They measure visits and traffic sources in order to better tailor the website to your needs.
Marketing These cookies provide you with interest-based advertising. They measure the success of our advertising, anonymized and aggregated. These cookies are also used to deliver you personalized and interest based content.